Skip to main content
Premium Trial:

Request an Annual Quote

Genome Therapeutics Extends Alliance With Astra Research Center

Premium

WALTHAM, Mass.--Genome Therapeutics here and Astra Research Center, a drug discovery company recently established in Cambridge, Mass., by Swedish pharmaceutical company, Astra, have extended until at least August, 1999, their alliance to identify and develop novel antiinfectives and vaccines to treat Helicobacter pylori, the organism associated with the onset of most peptic ulcers and certain stomach cancers. Announced in September 1995, the $22 million alliance centers around the genomic sequence of H. pylori, determined by Genome Therapeutics in 1994.

Genome Therapeutics also announced it has reached a milestone in its human genomics alliance with Schering-Plough to discover new therapeutics for treating asthma. The achievement triggers a milestone payment.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.